Epstein Secrets

esented the case to the U.S. Attomey’s Office for the Southern District of Florida. In 2007, the Office contacted counsel

rights even before prosecutors filed a superseding indictment covering the specific crimes affecting the victims. Citing Dean, the District Court for the Eastern District of New York agreed that the rights were expansive and could apply before charges were filed but were subject to the outer limit that the Government has at least

that implementing such an approach would be difficult.*” Presumably the Justice Department has already been providing such rights in at least Texas, Louisiana, and Mississippi to comply with the Fifth 197 See 18 U.S.C. §§ 2422(b), 2423(b), (e) (2012). 198 A more substantial summary of the case is availabl

sented the case to the U.S. Attorney's Office for the Southern District of Florida. In 2007, the Office contacted counsel

ights even before prosecutors filed a superseding indictment covering the specific crimes affecting the victims. Citing Dean, the District Court for the Eastern District of New York agreed that the rights ® John W. Gillis & Douglas E. Beloof, The Next Step for a Maturing Victim Rights Movement: Enforcing Crime Victim Rights in t

that implementing such an approach would be difficult. 7° Presumably the Justice Department has already been providing such rights in at least Texas, Louisiana, and Mississippi to comply with the Fifth [*95] Circuit's 2008 ruling in In Re Dean, which held that the CVRA extends rights to victims before defen

ense definitions to reduce opportunities for selective enforcement); Papachristou v. Jacksonville, 405 U.S. 156, 162 (1972) (same). 26 See Duncan v. Louisiana, 391 U.S. 145, 156 (1968) (regarding trial by jury as a "safeguard against the corrupt or overzealous prosecutor"). DAVID SCHOEN HOUSE_OVERSIGHT_01

onvincing Congress to expand their discretion at the expense of judges' sentencing authority, see United States v. Kupa, 976 F. Supp. 2d 417, 419-27 (E.D.N.Y. 2013) (describing the legislative history and Justice Department lobbying related to federal drug statutes, notably 27 U.S.C. § 841 (2012)). 218 See